Percutaneous debulking of tricuspid valve endocarditis in severe COVID-19 pneumonia after prolonged venovenous extracorporeal membrane oxygenation with right-ventricular support: a case series.
Kara F MortonBrittain F HeindlSamuel K McElweeSilvio LitovskyMustafa I AhmedStephen ClarksonPublished in: European heart journal. Case reports (2022)
VV-ECMO and right-ventricular support devices are invasive and create various risks, including bloodstream infection and infective endocarditis. Percutaneous debulking of valvular vegetations associated with these right-sided indwelling devices may be an effective means of infection source control. It is unclear whether prolonged use of VV-ECMO provides a mortality benefit in COVID-19 ARDS.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- coronavirus disease
- respiratory failure
- aortic valve
- sars cov
- neoadjuvant chemotherapy
- mitral valve
- minimally invasive
- ultrasound guided
- mechanical ventilation
- aortic stenosis
- radiofrequency ablation
- atrial fibrillation
- transcatheter aortic valve replacement
- cardiovascular events
- early onset
- squamous cell carcinoma
- risk factors
- human health
- respiratory syndrome coronavirus
- coronary artery disease
- lymph node
- intensive care unit
- risk assessment
- type diabetes
- escherichia coli
- urinary tract infection
- ejection fraction
- multidrug resistant